Akanda Corp. (AKAN)
NASDAQ: AKAN · Real-Time Price · USD
3.350
-0.320 (-8.72%)
At close: Sep 4, 2026, 4:00 PM EDT
3.410
+0.060 (1.79%)
After-hours: Sep 4, 2026, 7:59 PM EDT
Akanda Market Cap
Akanda has a market cap or net worth of $2.63 million as of September 4, 2026. Its market cap has decreased by -0.44% in one year.
Market Cap
2.63M
Enterprise Value
16.36M
1-Year Change
-0.44%
Ranking
Category
Stock Price
$3.35
ChartMarket Cap Chart
Since the IPO on March 15, 2022, Akanda's market cap has decreased from $302.99M to $2.63M, a decrease of -99.13%. That is a compound annual growth rate of -65.36%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 4, 2026 | 2.63M | 690.32% |
| Dec 31, 2025 | 333.02K | -85.41% |
| Dec 31, 2024 | 2.28M | 28.87% |
| Dec 29, 2023 | 1.77M | -63.24% |
| Dec 30, 2022 | 4.82M | -98.41% |
| Mar 15, 2022 | 302.99M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Sonoma Pharmaceuticals | 6.34M |
| InMed Pharmaceuticals | 6.16M |
| cbdMD | 5.33M |
| Sunshine Biopharma | 4.42M |
| RedHill Biopharma | 4.41M |
| Apimeds Pharmaceuticals US | 3.65M |
| PRF Technologies | 2.94M |
| BioXcel Therapeutics | 2.31M |